
The Chinese vaccine makers, Sinovac Biotech Ltd. and Hualan Biological Engineering Inc., have completed the clinical trials. Their products are claimed to be effective in single doses for population from three to 60 years. Sinovac claims the annual capacity to produce up to 30 million doses of swine flu vaccine, Hualan claims 160 million doses in a year.
If you would like to make a comment, please fill out the form below.